Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Shares Issued (2019 - 2025)

IDEAYA Biosciences' Shares Issued history spans 7 years, with the latest figure at -$820000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 107.01% year-over-year to -$820000.0; the TTM value through Sep 2025 reached $12.5 million, up 830.15%, while the annual FY2024 figure was $12.5 million, 929.1% up from the prior year.
  • Shares Issued for Q4 2025 was -$820000.0 at IDEAYA Biosciences, down from -$314000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $85.7 million in Q3 2021 and bottomed at -$84.5 million in Q4 2021.
  • The 5-year median for Shares Issued is $325000.0 (2021), against an average of $883666.7.
  • The largest annual shift saw Shares Issued tumbled 473.79% in 2023 before it skyrocketed 568.83% in 2024.
  • A 5-year view of Shares Issued shows it stood at -$84.5 million in 2021, then soared by 99.49% to -$435000.0 in 2022, then crashed by 473.79% to -$2.5 million in 2023, then surged by 568.83% to $11.7 million in 2024, then plummeted by 107.01% to -$820000.0 in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Shares Issued are -$820000.0 (Q4 2025), -$314000.0 (Q2 2025), and $1.1 million (Q1 2025).